Pacira Biosciences, INC Form 4 insider transactions

NASDAQ

5 Jun 2024

PCRX

Form 4: Pacira BioSciences Officer Jonathan Slonin Reports Tax-Related Stock Disposal

Jonathan Slonin, Chief Medical Officer of Pacira BioSciences, reports the disposal of 1,615 shares to cover tax obligations upon vesting of a restricted stock unit award.

NASDAQ

8 Mar 2024

PCRX

Pacira Biosciences, INC

Form 4: Pacira BioSciences Director Gary W. Pace Sells Shares in Multiple Transactions

Director Gary W. Pace of Pacira BioSciences, Inc. reported selling a significant number of shares in a series of transactions between March 6 and March 8, 2024.